Inhaled Aroxxen to protect the heart during stent placement
Part of Heart & circulation clinical trials.
This trial tests whether an inhaled medication called Aroxxen® can protect your heart during a planned stent procedure. It may help reduce stress on the heart muscle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have a planned (non-emergency) stent placement for a blocked heart artery.
- You have stable angina or a history of heart damage without current heart attack symptoms.
- Your heart damage marker (troponin) level is normal before the procedure.
- You are willing to follow all study visits and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a small device called a coronary sinus reducer that is placed in a vein of the heart to improve blood flow and reduce chest pain in people who still have angina despite medications and cannot have stents or bypass surgery. The procedure is done through a small tube in the groin or arm.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.